Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Induction of Ovulation Using Clomiphene Citrate and N-acetyl Cysteine Versus Letrozole
- Status
- COMPLETED
- Phase
- PHASE3
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE4
Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy
- Status
- TERMINATED
- Phase
- PHASE4
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Letrozole Step-up Protocol for Ovulation Induction in Infertile Women With PCOS
- Status
- COMPLETED
- Phase
- NA
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome
- Status
- UNKNOWN
- Phase
- PHASE3
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
- Status
- COMPLETED
- Phase
- PHASE2
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
- Status
- TERMINATED
- Phase
- PHASE3
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- Status
- RECRUITING
- Phase
- PHASE3
Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2